SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-15-003511
Filing Date
2015-08-18
Accepted
2015-08-18 20:06:50
Documents
2
Period of Report
2015-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1636
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3922
  Complete submission text file 0000899243-15-003511.txt   7075
Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354
Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address LISE-MEITNER-STRASSE 30 C/O PIERIS PHARMACEUTICALS, INC. FREISING-WEIHENSTEPHAN 2M 85354
Business Address
Matis Louis (Reporting) CIK: 0001650991 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37471 | Film No.: 151062666